Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Survival Benefit of the Adjunction of Pentoxifylline to Corticosteroids in Patients Suffering From Severe Alcoholic Hepatitis

NCT01214226 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT01214226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01214226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Survival Benefit of the Adjunction of Pentoxifylline to Corticosteroids in Patients Suffering From Severe Alcoholic Hepatitis
Lead sponsor
University Hospital, Lille
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2007
Completion date
January 31, 2011
Enrollment
278 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic hepatitis, alcoholic liver disease